← European Medicine Shortage Tracker · all medicines

Rivastigmin shortage — availability across Europe

Rivastigmin currently has availability issues reported in 3 European registers: Spain, Italy, Sweden.

MEDICALLY REVIEWED

Dr. Chrysoula I. Liakou MD, PhD

Internal Medicine Specialist
Cancer Immunology Researcher

Reviewed 30 July 2026 · next review due 30 January 2027

Shortage ATC — · also listed as: RIVASTIGMINA · rivastigmin · data refreshed 7 August 2026

Key facts

As of 7 August 2026, Rivastigmin has active availability issues in 3 of 10 tracked European registers.
Registers reporting issues: Spain, Italy, Sweden.
Latest expected-resolution date on file: 2026-11-12.
Longest-running open report: since 2021-10-15 (58 months, Italy).
Data source: 3 official medicines-agency registers, refreshed daily.

As of 7 August 2026, 3 of the 10 tracked registers list current availability issues for Rivastigmin, covering 21 affected product presentations. The longest-running open report was filed in Italy on 2021-10-15 and has now been open for about 58 months. Where agencies state a cause, manufacturing problems lead with 7 of the 9 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2026-11-12; the earliest is 2026-08-28. Momentum is current, not historical: 9 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2021-10-15), with Spain following roughly 53 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Where	Status & products	Since	Expected end	Reason / alternatives	Source
🇪🇸 Spain	Shortage RIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulas + 1 more products RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 30 parches (Papel/PET/PE/Al/LasPold)	2026-03-26	2026-11-12	Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.	register ↗
🇮🇹 Italy	Shortage EXELON + 8 more products NIMVASTID NIMVASTID NIMVASTID RIVASTIGMINA AUROBINDO RIVASTIGMINA MYLAN PHARMA RIVASTIGMINA ZENTIVA RIVASTIGMINA ZENTIVA RIVASTIGMINA ZENTIVA	2021-10-15	—	Cessata commercializzazione definitiva Alternatives: AIFA: equivalents with the same active substance are available.	register ↗
🇸🇪 Sweden	Shortage Exelon 4,6 mg/24 timmar Depotplåster + 9 more products Exelon 4,6 mg/24 timmar Depotplåster Rivastigmin STADA Arzneimittel 4,6 mg/24 timmar Depotplåster Rivastigmin STADA Arzneimittel 4,6 mg/24 timmar Depotplåster Rivastigmin STADA Arzneimittel 9,5 mg/24 timmar Depotplåster Rivastigmine Teva 4,6 mg/24 timmar Depotplåster Rivastigmine Teva 4,6 mg/24 timmar Depotplåster Rivastor 4,6 mg/24 timmar Depotplåster Rivastor 9,5 mg/24 timmar Depotplåster Rivastor 9,5 mg/24 timmar Depotplåster	2025-10-23	2026-10-01	— Alternatives: Alternative(s) available — see the national register.	register ↗

New register reports per month

Full report history (21 register entries)

Every individual register entry for Rivastigmin in the tracked sources, newest first — including resolved and discontinued reports.

Reg.	Product	Status	Reported	Expected end	Stated reason
🇮🇹 IT	EXELON	Shortage	2027-01-29	—	Cessata commercializzazione definitiva
🇸🇪 SE	Rivastigmin STADA Arzneimittel 9,5 mg/24 timmar Depotplåster	Expected shortage	2026-08-03	2026-09-30
🇸🇪 SE	Rivastor 9,5 mg/24 timmar Depotplåster	Expected shortage	2026-08-01	2026-10-01
🇸🇪 SE	Rivastigmin STADA Arzneimittel 4,6 mg/24 timmar Depotplåster	Shortage	2026-07-16	2026-09-30
🇸🇪 SE	Exelon 4,6 mg/24 timmar Depotplåster	Shortage	2026-07-15	2026-08-28
🇸🇪 SE	Exelon 4,6 mg/24 timmar Depotplåster	Shortage	2026-06-29	2026-09-03
🇮🇹 IT	RIVASTIGMINA AUROBINDO	Shortage	2026-06-01	—	Problemi produttivi
🇸🇪 SE	Rivastor 9,5 mg/24 timmar Depotplåster	Shortage	2026-06-01	2026-09-01
🇮🇹 IT	RIVASTIGMINA MYLAN PHARMA	Shortage	2026-05-18	—	Problemi produttivi
🇸🇪 SE	Rivastor 4,6 mg/24 timmar Depotplåster	Shortage	2026-05-04	2026-09-01
🇪🇸 ES	RIVASTIGMINA STADAFARMA 4,5 MG CAPSULAS DURAS EFG, 56 cápsulas	Shortage	2026-04-28	2026-11-12	Existen otros medicamentos con el mismo principio activo y m
🇸🇪 SE	Rivastigmin STADA Arzneimittel 4,6 mg/24 timmar Depotplåster	Shortage	2026-04-20	2026-09-14
🇸🇪 SE	Rivastigmine Teva 4,6 mg/24 timmar Depotplåster	Shortage	2026-04-17	2026-08-30
🇪🇸 ES	RIVASTIGMINA STADAFARMA 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 30 parc	Shortage	2026-03-26	—	Existen otros medicamentos con el mismo principio activo y m
🇮🇹 IT	NIMVASTID	Shortage	2026-03-03	—	Problemi produttivi
🇮🇹 IT	NIMVASTID	Shortage	2025-11-06	—	Problemi produttivi
🇸🇪 SE	Rivastigmine Teva 4,6 mg/24 timmar Depotplåster	Shortage	2025-10-23	2026-08-31
🇮🇹 IT	RIVASTIGMINA ZENTIVA	Shortage	2025-08-31	—	Elevata richiesta/problemi produttivi
🇮🇹 IT	RIVASTIGMINA ZENTIVA	Shortage	2024-09-09	—	Elevata richiesta
🇮🇹 IT	NIMVASTID	Shortage	2024-03-21	—	Problemi produttivi
🇮🇹 IT	RIVASTIGMINA ZENTIVA	Shortage	2021-10-15	—	Problemi produttivi: forniture discontinue

Frequently asked

Is Rivastigmin currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Spain, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Rivastigmin shortage expected to end?

Agency prognoses on file range from 2026-08-28 to 2026-11-12. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Rivastigmin?

21 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Rivastigmin availability data come from?

Directly from the official medicines-agency registers that list Rivastigmin: AEMPS CIMA (Spain), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rivastigmin — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rivastigmin/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rivastigmin availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rivastigmin/">Rivastigmin shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>

Cite: “Rivastigmin: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.